Related references
Note: Only part of the references are listed.Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Lucy Meunier et al.
VIRUSES-BASEL (2023)
Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
Cassia Leal et al.
VIRUSES-BASEL (2023)
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
Yuki Tahata et al.
JOURNAL OF GASTROENTEROLOGY (2022)
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus
Seiichi Mawatari et al.
PLOS ONE (2022)
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Victor Sapena et al.
GUT (2022)
Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma
Tamer Elbaz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals
Eiichi Ogawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma
Neehar D. Parikh et al.
CANCER (2022)
Clinical benefits of direct-acting antivirals therapy in hepatitis C virus patients with hepatocellular carcinoma: A systematic review and meta-analysis
Hui Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection
Jennifer R. Kramer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
Chen-Ta Chi et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
Young-Hwan Ahn et al.
GUT AND LIVER (2021)
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
Hironori Ochi et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Impact of direct-acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta-analysis
Yeva Sahakyan et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus
Takashi Kumada et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment
Yuan-Hung Kuo et al.
INVESTIGATIONAL NEW DRUGS (2020)
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis
Scott A. McDonald et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study
Gamal Shiha et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
Wei-Chen Lin et al.
PLOS ONE (2020)
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort
Elizabeth C. Verna et al.
JOURNAL OF HEPATOLOGY (2020)
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Angelo Sangiovanni et al.
JOURNAL OF HEPATOLOGY (2020)
Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C
Yamini Kalidindi et al.
JAMA NETWORK OPEN (2020)
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
Tatsuo Kanda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Zoe Marino et al.
JOURNAL OF HEPATOLOGY (2019)
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2019)
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
Elisabetta Degasperi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
Ana Lleo et al.
DIGESTIVE AND LIVER DISEASE (2019)
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016
Megan G. Hofmeister et al.
HEPATOLOGY (2019)
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Aakash Desai et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy
N. Saraiya et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
Darrick K. Li et al.
HEPATOLOGY (2018)
Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout
Annsa C. Huang et al.
HEPATOLOGY (2018)
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen
Hamish Innes et al.
JOURNAL OF HEPATOLOGY (2018)
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
Antonietta Romano et al.
JOURNAL OF HEPATOLOGY (2018)
Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis
M. El Kassas et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis
Chiara Masetti et al.
JOURNAL OF VIRAL HEPATITIS (2018)
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database
K. R. Reddy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
Sujan Ravi et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Philippe Kolly et al.
JOURNAL OF HEPATOLOGY (2017)
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Jose Luis Calleja et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
Hiroko Nagata et al.
JOURNAL OF HEPATOLOGY (2017)
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
Claudio Zavaglia et al.
JOURNAL OF HEPATOLOGY (2017)
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
R. Bielen et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Victor Virlogeux et al.
LIVER INTERNATIONAL (2017)
Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
Francesca Pezzuto et al.
INFECTIOUS AGENTS AND CANCER (2017)
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study
G. Cabibbo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma
Kenji Ikeda et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
Tatsuya Minami et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?
Qing-Lei Zeng et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatocellular carcinoma recurrence after treatment with direct -acting antivirals: First, do no harm by withdrawing treatment
Harrys A. Torres et al.
JOURNAL OF HEPATOLOGY (2016)
Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
Ju Dong Yang et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Michelle C. M. Cheung et al.
JOURNAL OF HEPATOLOGY (2016)
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
JOURNAL OF HEPATOLOGY (2016)
Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals
Norio Akuta et al.
ONCOLOGY (2016)
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Catherine de Martel et al.
HEPATOLOGY (2015)
Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go?
Hashem B. El-Serag et al.
HEPATOLOGY (2014)
Tumor Suppressors, Chromosomal Instability, and Hepatitis C Virus-Associated Liver Cancer
David R. McGivern et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Share Paper
